表紙
市場調查報告書

血液淨化設備:醫療設備的開發平台評估

Blood Purification Equipment - Medical Devices Pipeline Assessment, 2019

出版商 GlobalData 商品編碼 409609
出版日期 內容資訊 英文 202 Pages
訂單完成後即時交付
價格
Back to Top
血液淨化設備:醫療設備的開發平台評估 Blood Purification Equipment - Medical Devices Pipeline Assessment, 2019
出版日期: 2019年12月16日內容資訊: 英文 202 Pages
簡介

本報告提供全球血液淨化設備市場上主要的開發中產品 (醫療設備) 及其臨床實驗的進展調查,再彙整產品特性比較分析 (臨床實驗的各進展階段) ,主要企業簡介及代表性產品,近來的市場動靜 (資本交易·產業聯盟等) 資訊,為您概述為以下內容。

第1章 目錄

第2章 簡介

  • 血液淨化設備概要

第3章 現在臨床實驗中的產品

  • 開發中產品:各臨床實驗階段
  • 開發中產品:各領域
  • 開發中產品:各法規途徑
  • 開發中產品:各估計認證時期
  • 現在進行中的臨床實驗

第4章 血液淨化設備:各企業現在臨床實驗中的開發中產品

  • 血液淨化設備的企業:各臨床實驗階段的開發中產品
  • 血液淨化設備:各臨床實驗階段的開發中產品

第5章 血液淨化設備的企業·產品概要

  • Accel Diagnostics LLC
    • 開發中產品及進行中的臨床實驗概要
  • Aethlon Medical Inc
  • Cerus Corp
  • Children's Hospital Boston
  • Circle Biologics, LLC.
  • CytoSorbents Corp
  • Hansjorg Wyss Institute for Biologically Inspired Engineering
  • McGowan Institute for Regenerative Medicine
  • National University of Singapore
  • NxStage Medical Inc
  • Spectral Medical Inc
  • Stellarray, Inc.
  • TORAY MEDICAL COMPANY LIMITED

第6章 血液淨化設備市場:目前的趨勢

第7章 附錄

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDME0857EPD

GlobalData's Medical Devices sector report, "Blood Purification Equipment - Medical Devices Pipeline Assessment, 2019" provides an overview of Blood Purification Equipment currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Blood Purification Equipment pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Blood Purification Equipment under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Blood Purification Equipment and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Blood Purification Equipment under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

  • 1.1 List of Tables 6
  • 1.2 List of Figures 9

2 Introduction 10

  • 2.1 Blood Purification Equipment Overview 10

3 Products under Development 11

  • 3.1 Blood Purification Equipment - Pipeline Products by Stage of Development 11
  • 3.2 Blood Purification Equipment - Pipeline Products by Territory 12
  • 3.3 Blood Purification Equipment - Pipeline Products by Regulatory Path 14
  • 3.4 Blood Purification Equipment - Pipeline Products by Estimated Approval Date 15
  • 3.5 Blood Purification Equipment - Ongoing Clinical Trials 16

4 Blood Purification Equipment - Pipeline Products under Development by Companies 17

  • 4.1 Blood Purification Equipment Companies - Pipeline Products by Stage of Development 17
  • 4.2 Blood Purification Equipment - Pipeline Products by Stage of Development 18

5 Blood Purification Equipment Companies and Product Overview 20

  • 5.1 Accel Diagnostics LLC Company Overview 20
    • 5.1.1 Accel Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview 20
  • 5.2 Aethlon Medical Inc Company Overview 21
    • 5.2.1 Aethlon Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 21
  • 5.3 Asahi Kasei Medical Co Ltd Company Overview 25
    • 5.3.1 Asahi Kasei Medical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 25
  • 5.4 Boston Children's Hospital Company Overview 26
    • 5.4.1 Boston Children's Hospital Pipeline Products & Ongoing Clinical Trials Overview 26
  • 5.5 Cerus Corp Company Overview 27
    • 5.5.1 Cerus Corp Pipeline Products & Ongoing Clinical Trials Overview 27
  • 5.6 Chemofilter Inc (Inactive) Company Overview 34
    • 5.6.1 Chemofilter Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 34
  • 5.7 Cook Regentec LLC Company Overview 36
    • 5.7.1 Cook Regentec LLC Pipeline Products & Ongoing Clinical Trials Overview 36
  • 5.8 CytoSorbents Corp Company Overview 39
    • 5.8.1 CytoSorbents Corp Pipeline Products & Ongoing Clinical Trials Overview 39
  • 5.9 Delcath Systems Inc Company Overview 54
    • 5.9.1 Delcath Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 54
  • 5.10 EBO2 Inc Company Overview 59
    • 5.10.1 EBO2 Inc Pipeline Products & Ongoing Clinical Trials Overview 59
  • 5.11 Ex Vivo Dynamics Inc Company Overview 60
    • 5.11.1 Ex Vivo Dynamics Inc Pipeline Products & Ongoing Clinical Trials Overview 60
  • 5.12 Good SIRS Company Overview 61
    • 5.12.1 Good SIRS Pipeline Products & Ongoing Clinical Trials Overview 61
  • 5.13 HemoTune AG Company Overview 62
    • 5.13.1 HemoTune AG Pipeline Products & Ongoing Clinical Trials Overview 62
  • 5.14 Immunicom Inc Company Overview 63
    • 5.14.1 Immunicom Inc Pipeline Products & Ongoing Clinical Trials Overview 63
  • 5.15 McGowan Institute for Regenerative Medicine Company Overview 68
    • 5.15.1 McGowan Institute for Regenerative Medicine Pipeline Products & Ongoing Clinical Trials Overview 68
  • 5.16 MediSieve Ltd Company Overview 69
    • 5.16.1 MediSieve Ltd Pipeline Products & Ongoing Clinical Trials Overview 69
  • 5.17 Nipro Corp Company Overview 73
    • 5.17.1 Nipro Corp Pipeline Products & Ongoing Clinical Trials Overview 73
  • 5.18 Nonwovens Innovation & Research Institute Ltd Company Overview 74
    • 5.18.1 Nonwovens Innovation & Research Institute Ltd Pipeline Products & Ongoing Clinical Trials Overview 74
  • 5.19 NxStage Medical Inc Company Overview 75
    • 5.19.1 NxStage Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 75
  • 5.20 Opsonix Inc Company Overview 76
    • 5.20.1 Opsonix Inc Pipeline Products & Ongoing Clinical Trials Overview 76
  • 5.21 Path Ex Inc Company Overview 77
    • 5.21.1 Path Ex Inc Pipeline Products & Ongoing Clinical Trials Overview 77
  • 5.22 ProSorp BioTech Inc Company Overview 78
    • 5.22.1 ProSorp BioTech Inc Pipeline Products & Ongoing Clinical Trials Overview 78
  • 5.23 Spectral Medical Inc Company Overview 79
    • 5.23.1 Spectral Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 79
  • 5.24 Toray Medical Co Ltd Company Overview 82
    • 5.24.1 Toray Medical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 82
  • 5.25 Zata Pharmaceuticals Inc Company Overview 83
    • 5.25.1 Zata Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview 83

6 Blood Purification Equipment- Recent Developments 86

  • 6.1 Nov 25, 2019: CytoSorbents changes Contract Research Organizations and temporarily pauses enrollment in REFRESH 2-AKI Study 86
  • 6.2 Nov 19, 2019: Medtronic reports second quarter financial results for the year 2019 86
  • 6.3 Nov 14, 2019: Medtronic highlights leadership in inclusion, diversity, and equity in 2019 integrated performance report 88
  • 6.4 Nov 06, 2019: Dr. Eric Mortensen to leave CytoSorbents at year end 89
  • 6.5 Nov 05, 2019: CytoSorbents reports third quarter 2019 financial results 90

7 Appendix 199

  • 7.1 Methodology 199
  • 7.2 About GlobalData 202
  • 7.3 Contact Us 202
  • 7.4 Disclaimer 202

List of Tables

  • Table 1: Blood Purification Equipment - Pipeline Products by Stage of Development
  • Table 2: Blood Purification Equipment - Pipeline Products by Territory
  • Table 3: Blood Purification Equipment - Pipeline Products by Regulatory Path
  • Table 4: Blood Purification Equipment - Pipeline Products by Estimated Approval Date
  • Table 5: Blood Purification Equipment - Ongoing Clinical Trials
  • Table 6: Blood Purification Equipment Companies - Pipeline Products by Stage of Development
  • Table 7: Blood Purification Equipment - Pipeline Products by Stage of Development
  • Table 8: Accel Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 9: mPharesis - Product Status
  • Table 10: mPharesis - Product Description
  • Table 11: Aethlon Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 12: ASEPSYS Device - Product Status
  • Table 13: ASEPSYS Device - Product Description
  • Table 14: Hemopurifier - Product Status
  • Table 15: Hemopurifier - Product Description
  • Table 16: Aethlon Medical Inc - Ongoing Clinical Trials Overview
  • Table 17: Hemopurifier - An Early Feasibility Study of Hemopurifier in Patients with Head and Neck Cancer
  • Table 18: Hemopurifier - Plasma Exosome Concentration in Cancer Patients Undergoing Treatment
  • Table 19: Hemopurifier - Sepsis-related Virus Study of Aethlon Hemopurifier
  • Table 20: Asahi Kasei Medical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Table 21: Mysorba - Product Status
  • Table 22: Mysorba - Product Description
  • Table 23: Boston Children's Hospital Pipeline Products & Ongoing Clinical Trials Overview
  • Table 24: Blood Filtration Device - Product Status
  • Table 25: Blood Filtration Device - Product Description
  • Table 26: Cerus Corp Pipeline Products & Ongoing Clinical Trials Overview
  • Table 27: INTERCEPT Blood System - Platelets - Product Status
  • Table 28: INTERCEPT Blood System - Platelets - Product Description
  • Table 29: INTERCEPT Blood System - Red Blood Cells - Product Status
  • Table 30: INTERCEPT Blood System - Red Blood Cells - Product Description
  • Table 31: INTERCEPT Blood System - Zika Virus - Product Status
  • Table 32: INTERCEPT Blood System - Zika Virus - Product Description
  • Table 33: Cerus Corp - Ongoing Clinical Trials Overview
  • Table 34: INTERCEPT Blood System - Platelets - A Randomized, Multi-center, Multi-Stage, Controlled, In Vivo Study to Assess the Recovery and Survival of Radiolabeled Autologous INTERCEPT Apheresis Platelet Components Suspended in 100% Plasma Stored for up to 7 Days
  • Table 35: INTERCEPT Blood System - Red Blood Cells - A Randomized, Double-blinded, Controlled, Parallel Group, Non-inferiority, Phase III Study to Evaluate the Efficacy and Safety of the INTERCEPT Blood System for Red Blood Cells in Patients Undergoing Complex Cardiac Surgery Procedures
  • Table 36: INTERCEPT Blood System - Red Blood Cells - Measurement of the Recovery and Lifespan of Red Blood Cells from Pathogen-reduced, Stored Blood Units Using Cellular Biotinylation
  • Table 37: INTERCEPT Blood System - Red Blood Cells - Randomized, Double-blind, Controlled, Parallel Group Study with the INTERCEPT Blood System for RBCs in Regions at Potential Risk for Zika Virus Transfusion-transmitted Infections and Treatment Use Open-label Extension Study
  • Table 38: Chemofilter Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
  • Table 39: ChemoFilter Device - Product Status
  • Table 40: ChemoFilter Device - Product Description
  • Table 41: Next-Generation ChemoFilter Device - Product Status
  • Table 42: Next-Generation ChemoFilter Device - Product Description
  • Table 43: Cook Regentec LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 44: HemaTrate - Critical Limb Ischemia - Product Status
  • Table 45: HemaTrate - Critical Limb Ischemia - Product Description
  • Table 46: Cook Regentec LLC - Ongoing Clinical Trials Overview
  • Table 47: HemaTrate - Critical Limb Ischemia - Clinical Study of the Use of an Autologous Blood Filtration Device in the Treatment of Critical Limb Ischemia
  • Table 48: CytoSorbents Corp Pipeline Products & Ongoing Clinical Trials Overview
  • Table 49: BetaSorb - Product Status
  • Table 50: BetaSorb - Product Description
  • Table 51: ContrastSorb - Product Status
  • Table 52: ContrastSorb - Product Description
  • Table 53: CST 301 - Product Status
  • Table 54: CST 301 - Product Description
  • Table 55: CytoSorb - Product Status
  • Table 56: CytoSorb - Product Description
  • Table 57: CytoSorb-XL - Product Status
  • Table 58: CytoSorb-XL - Product Description
  • Table 59: DrugSorb - Product Status
  • Table 60: DrugSorb - Product Description
  • Table 61: HemoDefend - Product Status
  • Table 62: HemoDefend - Product Description

List of Figures

  • Figure 1: Blood Purification Equipment - Pipeline Products by Stage of Development
  • Figure 2: Blood Purification Equipment - Pipeline Products by Territory
  • Figure 3: Blood Purification Equipment - Pipeline Products by Regulatory Path
  • Figure 4: Blood Purification Equipment - Pipeline Products by Estimated Approval Date
  • Figure 5: Blood Purification Equipment - Ongoing Clinical Trials
Back to Top